IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
176
$10K ﹤0.01%
+134
177
$9K ﹤0.01%
53
178
$8K ﹤0.01%
22
179
– –
0
180
– –
0
181
– –
0
182
– –
0
183
– –
0
184
– –
0
185
– –
-235,587
186
– –
0
187
– –
0
188
– –
0
189
– –
0
190
– –
-1,758
191
– –
0
192
– –
-62,059
193
– –
-4,240
194
– –
0
195
– –
0
196
– –
0
197
– –
-333
198
– –
0
199
– –
-13,000
200
– –
0
6 7
8
9 10